Orexins and their receptors: Structural aspects and role in peripheral tissues

Cellular and Molecular Life Sciences

Volumn 60, Issue 1, 2003, Pages 72-87

  Voisin, T ^a   Rouet Benzineb, P ^a   Reuter, N ^a   Laburthe, M ^a  

^a INSERM   (France)

Author keywords

Food intake; Gastrointestinal tract; Hypothalamus pituitary adrenal axis; Narcolepsy; Neuropeptide; Pharmacology; Signal transduction

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; 3 QUINOLIN 4 YL 3 NAPHTHYRIDIN 4 YLUREA; CALCIUM ION; COMPLEMENTARY DNA; ENZYME; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; NEUROPEPTIDE; OREXIN; OREXIN A; OREXIN B; OREXIN RECEPTOR; PROTEIN INHIBITOR; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

AUTONOMIC NERVOUS SYSTEM; CALCIUM MOBILIZATION; CENTRAL NERVOUS SYSTEM; FEEDING; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTESTINE FUNCTION; MOLECULAR CLONING; NARCOLEPSY; NEUROENDOCRINOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; SLEEP DISORDER; SLEEP WAKING CYCLE; TISSUE;

EID: 0037278502     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180300005     Document Type: Review

References (112)

1. Gautvik K. M., Lecea L. de, Gautvik V. T., Danielson P. E., Tranque P., Dopazo A. et al. (1996) Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proc. Natl. Acad. Sci. USA 93: 8733-8738
2. Lecea L. de, Kilduff T. S., Peyron C., Gao X., Foye P. E., Danielson P. E. et al. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 95: 322-327
3. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R. M., Tanaka H. et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585
4. Willie J. T., Chemelli R. M., Sinton C. M. and Yanagisawa M. (2001) To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci. 24: 429-458
5. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K. et al. (1999) Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc. Natl. Acad. Sci. USA 96: 748-753
6. Peyron C., Tighe D. K., Den Pol A. N. van, Lecea L. de, Heller H. C., Sutcliffe J. G. et al. (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 18: 9996-10015
7. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X. et al. (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98: 365-376
8. Chemelli R. M., Willie J. T., Sinton C. M., Elmquist J. K., Scammell T., Lee C. et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437-451
9. Mignot E. and Thorsby E. (2001) Narcolepsy and the HLA system. N. Engl. J. Med. 344: 692
10. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y. et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6: 991-997
11. Olafsdottir B. R., Rye D. B., Scammell T. E., Matheson J. K., Stefansson K. and Gulcher J. R. (2001) Polymorphisms in hypocretin/orexin pathway genes and narcolepsy. Neurology 57: 1896-1899
12. Hungs M., Fan J., Lin L., Lin X., Maki R. A. and Mignot E. (2001) Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res. 11: 531-539
13. Overeem S., Mignot E., Gert v. D. and Lammers G. J. (2001) Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J. Clin. Neurophysiol. 18: 78-105
14. Lin L., Hungs M. and Mignot E. (2001) Narcolepsy and the HLA region. J. Neuroimmunol. 117: 9-20
15. Hungs M. and Mignot E. (2001) Hypocretin/orexin, sleep and narcolepsy. Bioessays 23: 397-408
16. Lecea L. de and Sutcliffe J. G. (1999) The hypocretins/orexins: novel hypothalamic neuropeptides involved in different physiological systems. Cell. Mol. Life Sci. 56: 473-480
17. Sutcliffe J. G. and Lecea L. de (2000) The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J. Neurosci. Res. 62: 161-168
18. Kilduff T. S. and Peyron C. (2000) The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci. 23: 359-365
19. Halford J. C. and Blundell J. E. (2000) Pharmacology of appetite suppression. Prog. Drug Res. 54: 25-58
20. Sakurai T. (1999) Orexins and orexin receptors: implication in feeding behavior. Regul. Pept. 85: 25-30
21. Siegel J. M. (1999) Narcolepsy: a key role for hypocretins (orexins). Cell 98: 409-412
22. Meier C. A. (1998) Orexins and anorexins: thoughts for food. Eur. J. Endocrinol. 139: 148-149
23. Wolf G. (1998) Orexins: a newly discovered family of hypothalamic regulators of food intake. Nutr. Rev. 56: 172-173
24. Shibahara M., Sakurai T., Nambu T., Takenouchi T., Iwaasa H., Egashira S. I. et al. (1999) Structure, tissue distribution, and pharmacological characterization of Xenopus orexins. Peptides 20: 1169-1176
25. Lee J. H., Bang E., Chae K. J., Kim J. Y., Lee D. W. and Lee W. (1999) Solution structure of a new hypothalamic neuropeptide, human hypocretin-2/orexin-B. Eur. J. Biochem. 266: 831-839
26. Smart D., Sabido-David C., Brough S. J., Jewitt E, Johns A., Porter R. A. et al. (2001) SB-334867-A: the first selective orexin-1 receptor antagonist. Br. J. Pharmacol. 132: 1179-1182
27. Kane J. K., Parker S. L. and Li M. D. (2001) Hypothalamic orexin-A binding sites are downregulated by chronic nicotine treatment in the rat. Neurosci. Lett. 298: 1-4
28. Holmqvist T., Akerman K. E. and Kukkonen J. P. (2001) High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides. Neurosci. Lett. 305: 177-180
29. Laburthe M., Couvineau A., Amiranoff B. and Voisin T. (1994) Receptors for gut regulatory peptides. Baillieres Clin. Endocrinol. Metab. 8: 77-110
30. Okumura T., Takeuchi S., Motomura W., Yamada H., Egashira S. S., Asahi S. et al. (2001) Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation. Biochem. Biophys. Res. Commun. 280: 976-981
31. Smart D., Jerman J. C., Brough S. J., Neville W. A., Jewitt E and Porter R. A. (2000) The hypocretins are weak agonists at recombinant human orexin-1 and orexin-2 receptors. Br. J. Pharmacol. 129: 1289-1291
32. 2+ influx pathway necessary for coupling to phospholipase C. J. Biol. Chem. 275: 30806-30812
33. Darker J. G., Porter R. A., Eggleston D. S., Smart D., Brough S. J., Sabido-David C. et al. (2001) Structure-activity analysis of truncated orexin-A analogues at the orexin-1 receptor. Bioorg. Med. Chem. Lett. 11: 737-740
34. Den Pol A. N. van, Gao X. B., Obrietan K., Kilduff T. S. and Belousov A. B. (1998) Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J. Neurosci. 18: 7962-7971
35. 2+ channels. Neuroreport 12: 2017-2020
36. Malendowicz L. K., Tortorella C. and Nussdorfer G. G. (1999) Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade. J. Steroid Biochem Mol. Biol. 70: 185-188
37. Mazzocchi G., Malendowicz L. K., Gottardo L., Aragona F. and Nussdorfer G. G. (2001) Orexin A stimulates cortisol secretion from human adrenocortical cells through activation of the adenylate cyclase-dependent signaling cascade. J. Clin. Endocrinol. Metab. 86: 778-782
38. Nanmoku T., Isobe K., Sakurai T., Yamanaka A., Takekoshi K., Kawakami Y. et al. (2000) Orexins suppress catecholamine synthesis and secretion in cultured PC12 cells. Biochem. Biophys. Res. Commun. 274: 310-315
39. Randeva H. S., Karteris E., Grammatopoulos D. and Hillhouse E. W. (2001) Expression of orexin-A and functional orexin type 2 receptors in the human adult adrenals: implications for adrenal function and energy homeostasis. J. Clin. Endocrinol. Metab. 86: 4808-4813
40. Porter R. A., Chan W. N., Coulton S., Johns A., Hadley M. S., Widdowson K. et al. (2001) 1,3-Biarylureas as selective nonpeptide antagonists of the orexin-1 receptor. Bioorg. Med. Chem. Lett. 11: 1907-1910
41. Haynes A. C., Jackson B., Chapman H., Tadayyon M., Johns A., Porter R. A. et al. (2000) A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul. Pept. 96: 45-51
42. Rodgers R. J., Halford J. C., Nunes de Souza R. L., Canto de Souza A. L., Piper D. C., Arch J. R. et al. (2001) SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur. J. Neurosci. 13: 1444-1452
43. Trivedi P.,Yu H., MacNeil D. J., Van der Ploeg L. H. and Guan X. M (1998) Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 438: 71-75
44. Marcus J. N., Aschkenasi C. J., Lee C. E., Chemelli R. M., Saper C. B., Yanagisawa M. et al. (2001) Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435: 6-25
45. Johren O., Neidert S. J., Kummer M., Dendorfer A. and Dominiak P. (2001) Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 142: 3324-3331
46. Dalal M. A., Schuld A., Haack M., Uhr M., Geisler P., Eisensehr I. et al. (2001) Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients. Neurology 56: 1749-1751
47. Higuchi S., Usui A., Murasaki M., Matsushita S., Nishioka N., Yoshino A. et al. (2002) Plasma orexin-A is lower in patients with narcolepsy. Neurosci. Lett. 318: 61-64
48. Arihara Z., Takahashi K., Murakami O., Totsune K., Sone M., Satoh F. et al. (2001) Immunoreactive orexin-A in human plasma. Peptides 22: 139-142
49. Karteris E., Randeva H. S., Grammatopoulos D. K., Jaffe R. B. and Hillhouse E. W. (2001) Expression and coupling characteristics of the CRH and orexin type 2 receptors in human fetal adrenals. J. Clin. Endocrinol. Metab. 86: 4512-4519
50. Kirchgessner A. L. and Liu M. (1999) Orexin synthesis and response in the gut. Neuron 24: 941-951
51. Date Y., Mondal M. S., Matsukura S., Ueta Y., Yamashita H., Kaiya H. et al. (2000) Distribution of orexin/hypocretin in the rat median eminence and pituitary. Brain Res. Mol. Brain Res. 76: 1-6
52. Tamura T., Irahara M., Tezuka M., Kiyokawa M. and Aono T. (1999) Orexins, orexigenic hypothalamic neuropeptides, suppress the pulsatile secretion of luteinizing hormone in ovariectomized female rats. Biochem. Biophys. Res. Commun. 264: 759-762
53. Russell S. H., Small C. J., Kennedy A. R., Stanley S. A., Seth A., Murphy K. G. et al. (2001) Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology 142: 5294-5302
54. Pu S., Jain M. R., Kalra P. S. and Kalra S. P. (1998) Orexins, a novel family of hypothalamic neuropeptides, modulate pituitary luteinizing hormone secretion in an ovarian steroid-dependent manner. Regul. Pept. 78: 133-136
55. Mitsuma T., Hirooka Y., Mori Y., Kayama M., Adachi K., Rhue N. et al. (1999) Effects of orexin A on thyrotropin-releasing hormone and thyrotropin secretion in rats. Horm. Metab. Res. 31: 606-609
56. Hagan J. J., Leslie R. A., Patel S., Evans M. L., Wattam T. A., Holmes S. et al. (1999) Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl. Acad. Sci. USA 96: 10911-10916
57. Russell S. H., Kim M. S., Small C. J., Abbott C. R., Morgan D. G., Taheri S. et al. (2000) Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin. J. Neuroendocrinol. 12: 1213-1218
58. Blanco M., Lopez M., GarcIa-Caballero T., Gallego R., Vazquez-Boquete A., Morel G. et al. (2001) Cellular localization of orexin receptors in human pituitary. J. Clin. Endocrinol. Metab. 86: 1616-1619
59. Samson W. K., Taylor M. M., Follwell M. and Ferguson A. V. (2002) Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul. Pept. 104: 97-103
60. Russell S. H., Small C. J., Dakin C. L., Abbott C. R., Morgan D. G., Ghatei M. A. et al. (2001) The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. J. Neuroendocrinol. 13: 561-566
61. Kuru M., Ueta Y., Serino R., Nakazato M., Yamamoto Y., Shibuya I. et al. (2000) Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport 11: 1977-1980
62. Al Barazanji K. A., Wilson S., Baker J., Jessop D. S. and Harbaz M. S. (2001) Central orexin-A activates hypothalamic-pituitary-adrenal axis and stimulates hypothalamic corticotropin releasing factor and arginine vasopressin neurones in conscious rats. J. Neuroendocrinol. 13: 421-424
63. Samson W. K. and Taylor M. M. (2001) Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281: R1140-R1145
64. Jaszberenyi M., Bujdoso E., Pataki I. and Telegdy G. (2000) Effects of orexins on the hypothalamic-pituitary-adrenal system. J. Neuroendocrinol. 12: 1174-1178
65. Malendowicz L. K., Jedrzejczak N., Belloni A. S., Trejter M., Hochol A. and Nussdorfer G. G. (2001) Effects of orexins A and B on the secretory and proliferative activity of immature and regenerating rat adrenal glands. Histol. Histopathol. 16: 713-717
66. Lopez M., Senaris R., Gallego R., Garcia-Caballero T., Lago F., Seoane L. et al. (1999) Orexin receptors are expressed in the adrenal medulla of the rat. Endocrinology 140: 5991-5994
67. Malendowicz L. K., Hochol A., Ziolkowska A., Nowak M., Gottardo L. and Nussdorfer G. G. (2001) Prolonged orexin administration stimulates steroid-hormone secretion, acting directly on the rat adrenal gland. Int. J. Mol. Med. 7: 401-404
68. Blanco M., Garcia-Caballero T., Fraga M., Gallego R., Cuevas J., Forteza J. et al. (2002) Cellular localization of orexin receptors in human adrenal gland, adrenocortical adenomas and pheochromocytomas. Regul. Pept. 104: 161-165
69. Mazzocchi G., Malendowicz L. K., Aragona F., Rebuffat P., Gottardo L. and Nussdorfer G. G. (2001) Human pheochromocytomas express orexin receptor type 2 gene and display an in vitro secretory response to orexins A and B. J. Clin. Endocrinol. Metab. 86: 4818-4821
70. Nanmoku T., Isobe K., Sakurai T, Yamanaka A., Takekoshi K., Kawakami Y. et al. (2002) Effects of orexin on cultured porcine adrenal medullary and cortex cells. Regul. Pept. 104: 125-130
71. Takahashi N., Okumura T., Yamada H. and Kohgo Y. (1999) Stimulation of gastric acid secretion by centrally administered orexin-A in conscious rats. Biochem Biophys. Res. Commun. 254: 623-627
72. Miguel M. J. de and Burrell M. A. (2002) Immunocytochemical detection of orexin A in endocrine cells of the developing mouse gut. J. Histochem Cytochem. 50: 63-70
73. Naslund E., Ehrstrom M., Ma J., Hellstrom P. M. and Kirchgessner A. L. (2002) Localization and effects of orexin on fasting motility in the rat duodenum. Am. J. Physiol. Gastrointest. Liver Physiol. 282: G470-G479
74. Scammell T. E., Nishino S., Mignot E. and Saper C. B. (2001) Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke. Neurology 56: 1751-1753
75. Nowak K. W., Mackowiak P., Switonska M. M., Fabis M. and Malendowicz L. K. (2000) Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies. Life Sci. 66: 449-454
76. Switonska M. M., Kaczmarek P., Malendowicz L. K. and Nowak K. W. (2002) Orexins and adipoinsular axis function in the rat. Regul. Pept. 104: 69-73
77. Oldfield B. J., Giles M. E., Watson A., Anderson C., Colvill L. M. and McKinley M. J. (2002) The neurochemical characterisation of hypothalamic pathways projecting polysynaptically to brown adipose tissue in the rat. Neuroscience 110: 515-526
78. Rehfeld J. F. (1989) Cholecystokinin. In: Handbook of Physiology, section 6, The Gastrointestinal System, vol. II, Neural and Endocrine Biology, pp 337-358, Makhlouf G. M. (ed.), American Physiological Society, Bethesda
79. Dockray G. J. and Gregory R. A. (1989) Gastrin. In: Handbook of Physiology, section 6, The Gastrointestinal System, vol. II, Neural and Endocrine Biology, pp 311-336, Makhlouf G. M. (ed.), American Physiological Society, Bethesda
80. Brown J. C., Buchan A. M. J., McIntosh C. H. S. and Pederson R. A. (1989) Gastric inhibitory polypeptide. In: Handbook of Physiology, section 6, The Gastrointestinal system, vol. II, Neural and Endocrine Biology, pp 403-430, Makhlouf G. M. (ed.), American Physiological Society, Bethesda
81. Taylor I. L. (1989) Pancreatic polypeptide family: pancreatic polypeptide, neuropeptide Y, and peptide YY. In: Handbook of Physiology, section 6, The Gastrointestinal system, vol. II, Neural and Endocrine Biology, pp 475-544, Makhlouf G. M. (ed.), American Physiological Society, Bethesda
82. Dyer C. J., Touchette K. J., Carroll J. A., Allee G. L. and Matteri R. L. (1999) Cloning of porcine prepro-orexin cDNA and effects of an intramuscular injection of synthetic porcine orexin-B on feed intake in young pigs. Domest. Anim. Endocrinol. 16: 145-148
83. Hervieu G. J., Cluderay J. E., Harrison D. C., Roberts J. C. and Leslie R. A. (2001) Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 103: 777-797
84. Mitsuma T., Hirooka Y., Kayama M., Mori Y., Yokoi Y., Rhue N. et al. (2000) Radioimmunoassay for orexin A. Life Sci. 66: 897-904
85. Salin-Pascual R., Gerashchenko D., Greco M., Blanco-Centurion C. and Shiromani P. J. (2001) Hypothalamic regulation of sleep. Neuropsychopharmacology 25: S21-S27
86. Krahn L. E., Black J. L. and Silber M. H. (2001) Narcolepsy: new understanding of irresistible sleep. Mayo Clin. Proc. 76: 185-194
87. Farina B., Della M. G., Mazza M., Mennuni G. and Mazza S. (2000) New perspectives in the diagnosis and therapy of narcolepsy. Clin. Ter. 151: 357-363
88. Bierbrauer J., Heidenreich T., Hilwerling L., Nessen S. von, Fey P., Kogel P. et al. (2000) Narcolepsy: an illness in transition. Nervenarzt 71: 807-812
89. Fukagawa K. and Sakata T (2001) Genetic abnormality and the mechanism of ingestive disorder in obese animal model. Nippon Rinsho 59: 466-471
90. Shimizu H. and Mori M. (2001) Role of leptin and its receptor in the regulation of appetite and body fat. Nippon Rinsho 59: 421-426
91. Aou S. (2001) Physiology of appetite and feeding behavior: introduction. Nippon Rinsho 59: 407-412
92. Bray G. A. (2000) Reciprocal relation of food intake and sympathetic activity: experimental observations and clinical implications. Int. J. Obes. Relat. Metab. Disord. 24 (suppl 2): S8-S17
93. Meister B. (2000) Control of food intake via leptin receptors in the hypothalamus. Vitam. Horm. 59: 265-304
94. Chen C. T., Hwang L. L., Chang J. K. and Dun N. J. (2000) Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278: R692-R697
95. Kunii K., Yamanaka A., Nambu T, Matsuzaki I., Goto K. and Sakurai T. (1999) Orexins/hypocretins regulate drinking behaviour. Brain Res. 842: 256-261
96. McGranaghan P. A. and Piggins H. D. (2001) Orexin A-like immunoreactivity in the hypothalamus and thalamus of the Syrian hamster (Mesocricetus auratus) and Siberian hamster (Phodopus sungorus), with special reference to circadian structures. Brain Res. 904: 234-244
97. Fujiki N., Yoshida Y., Ripley B., Honda K., Mignot E. and Nishino S. (2001) Changes in CSF hypocretin-1 (orexin A) levels in rats across 24 hours and in response to food deprivation. Neuroreport 12: 993-997
98. Piper D. C., Upton N., Smith M. I. and Hunter A. J. (2000) The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur. J. Neurosci. 12: 726-730
99. Taheri S., Ward H., Ghatei M. and Bloom S. (2000) Role of orexins in sleep and arousal mechanisms. Lancet 355: 847
100. Yamanaka A., Kunii K., Nambu T., Tsujino N., Sakai A., Matsuzaki I. et al. (2000) Orexin-induced food intake involves neuropeptide Y pathway. Brain Res. 859: 404-409
101. Balasko M., Szelenyi Z. and Szekely M. (1999) Central thermoregulatory effects of neuropeptide Y and orexin A in rats. Acta Physiol. Hung. 86: 219-222
102. Lubkin M. and Stricker-Krongrad A. (1998) Independent feeding and metabolic actions of orexins in mice. Biochem. Biophys. Res. Commun. 253: 241-245
103. Shirasaka T., Nakazato M., Matsukura S., Takasaki M. and Kannan H. (1999) Sympathetic and cardiovascular actions of orexins in conscious rats. Am. J. Physiol. 277: R1780-R1785
104. Samson W. K., Gosnell B., Chang J. K., Resch Z. T. and Murphy T. C. (1999) Cardiovascular regulatory actions of the hypocretins in brain. Brain Res. 831: 248-253
105. Kiyashchenko L. I., Mileykovskiy B. Y., Lai Y. Y. and Siegel J. M. (2001) Increased and decreased muscle tone with orexin (hypocretin) microinjections in the locus coeruleus and pontine inhibitory area. J. Neurophysiol. 85: 2008-2016
106. Irahara M., Tamura T., Matuzaki T., Saito S., Yasui T., Yamano S. et al. (2001) Orexin-A suppresses the pulsatile secretion of luteinizing hormone via beta-endorphin. Biochem. Biophys. Res. Commun. 281: 232-236
107. Jaszberenyi M., Bujdoso E. and Telegdy G. (2001) The role of neuropeptide Y in orexin-induced hypothalamic-pituitary-adrenal activation. J. Neuroendocrinol. 13: 438-441
108. Kohsaka A., Watanobe H., Kakizaki Y., Suda T. and Schioth H. B. (2001) A significant participation of orexin-A, a potent orexigenic peptide, in the preovulatory luteinizing hormone and prolactin surges in the rat. Brain Res. 898: 166-170
109. Nakamura T., Uramura K., Nambu T., Yada T., Goto K., Yanagisawa M. et al. (2000) Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Res. 873: 181-187
110. Thakkar M. M., Ramesh V., Strecker R. E. and McCarley R. W. (2001) Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch. Ital. Biol. 139: 313-328
111. Satoh Y., Uchida M., Fujita A., Nishio H., Takeuchi T. and Hata F. (2001) Possible role of orexin A in nonadrenergic, noncholinergic inhibitory response of muscle of the mouse small intestine. Eur. J. Pharmacol. 428: 337-342
112. Ichinose M., Asai M., Sawada M, Sasaki K. and Oomura Y. (1998) Induction of outward current by orexin-B in mouse peritoneal macrophages. FEBS Lett. 440: 51-54